صورة الغلاف المحلية
صورة الغلاف المحلية
صور من OpenLibrary

Bone metabolism and turnover markers in children with steroid-dependant \ frequently-relapsing and steroid- resistant nephrotic syndrome / Athar Marwan Abdelaliem Ibrahim ; Supervised Emad Emil Ghobrial , Hanan Abdelaziz Ahmed , Riham Elsayed Hanafy

بواسطة: المساهم: نوع المادة : نصاللغة: الإنجليزية تفاصيل النشر: Cairo : Athar Marwan Abdelaliem Ibrahim , 2016الوصف: 122 P. : charts , facsimiles ; 25cmعنوان آخر:
  • علامات التغير فى مكونات العظام لأطفال المصابين بالمتلازمة النفروزية المعتمدة على العلاج والغير مستجيبة للعلاج - بالكورتيزون [عنوان مضاف عنوان الصفحة]
الموضوع: موارد على الإنترنت: Available additional physical forms:
  • Issued also as CD
ملاحظة الأطروحة: Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Pediatrics ملخص: Background: Children with nephrotic syndrome may be at risk for metabolic bone disease because of biochemical derangement caused by renal disease as well as steroid therapy. Objectives: The aim of the work was to evaluate linear growth and bone turnover markers (Calcium, Phosphorus, Alkaline phosphatase and Osteocalcin) in nephrotic syndrome patients specially SDNS{u2215}FRNS and SRNS patients in comparison to a matched control group. Methods: The study is a cross sectional case-control study that included 30 patients with SDNS{u2215}FRNS and 30 SRNS patients aged 2-15 years matched with 28 healthy control children. Both patients and controls was subjected to clinical examination and we measured serum calcium, phosphorus, alkaline phosphatase and osteocalcin). Results: Height of both SDNS{u2215}FRNS and SRNS showed lower height for age percentile compared to control group (p=0.017 and 0.00 respectively). Also height of all NS patients were negatively correlated to duration of steroid, cyclophosphamide (CYP) and cyclosporine therapy (p= 0.05, p= 0.044 and 0.02 respectively).Lower serum calcium levels were (mean 8.9±0.8) mg/dL and significant lower calcium levels in all NS patients compared to the control group (P=0.0001). Higher ALP levels in both SDNS{u2215}FRNS and SRNS patients compared to control group but with statistical significance for only SRNS patients (p= 0.02). Higher Serum osteocalcin levels in both SDNS{u2215}FRNS and SRNS patients groups compared to the control group (P=0.02 and 0.01 respectively). We also found that osteocalcin levels were negatively correlated to serum calcium levels of our patients (p-value = 0.0001). Conclusion: Glucocorticoids therapy of NS patients especially on long term treatment in SDNS{u2215}FRNS and SRNS patients affects the height of patients and some markers of bone metabolism in the form of decrease serum Calcium level and increase serum alkaline phosphatase and osteocalcin level
وسوم من هذه المكتبة: لا توجد وسوم لهذا العنوان في هذه المكتبة. قم بتسجيل الدخول لإضافة الوسوم.
التقييم باستخدام النجوم
    متوسط التقييم: 0.0 (0 صوتًا)
المقتنيات
نوع المادة المكتبة الحالية المكتبة الرئيسية رقم الاستدعاء رقم النسخة حالة الباركود
Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.28.M.Sc.2016.At.B (استعراض الرف(يفتح أدناه)) لا تعار 01010110069961000
CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.28.M.Sc.2016.At.B (استعراض الرف(يفتح أدناه)) 69961.CD لا تعار 01020110069961000

Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Pediatrics

Background: Children with nephrotic syndrome may be at risk for metabolic bone disease because of biochemical derangement caused by renal disease as well as steroid therapy. Objectives: The aim of the work was to evaluate linear growth and bone turnover markers (Calcium, Phosphorus, Alkaline phosphatase and Osteocalcin) in nephrotic syndrome patients specially SDNS{u2215}FRNS and SRNS patients in comparison to a matched control group. Methods: The study is a cross sectional case-control study that included 30 patients with SDNS{u2215}FRNS and 30 SRNS patients aged 2-15 years matched with 28 healthy control children. Both patients and controls was subjected to clinical examination and we measured serum calcium, phosphorus, alkaline phosphatase and osteocalcin). Results: Height of both SDNS{u2215}FRNS and SRNS showed lower height for age percentile compared to control group (p=0.017 and 0.00 respectively). Also height of all NS patients were negatively correlated to duration of steroid, cyclophosphamide (CYP) and cyclosporine therapy (p= 0.05, p= 0.044 and 0.02 respectively).Lower serum calcium levels were (mean 8.9±0.8) mg/dL and significant lower calcium levels in all NS patients compared to the control group (P=0.0001). Higher ALP levels in both SDNS{u2215}FRNS and SRNS patients compared to control group but with statistical significance for only SRNS patients (p= 0.02). Higher Serum osteocalcin levels in both SDNS{u2215}FRNS and SRNS patients groups compared to the control group (P=0.02 and 0.01 respectively). We also found that osteocalcin levels were negatively correlated to serum calcium levels of our patients (p-value = 0.0001). Conclusion: Glucocorticoids therapy of NS patients especially on long term treatment in SDNS{u2215}FRNS and SRNS patients affects the height of patients and some markers of bone metabolism in the form of decrease serum Calcium level and increase serum alkaline phosphatase and osteocalcin level

Issued also as CD

لا توجد تعليقات على هذا العنوان.

اضغط على الصورة لمشاهدتها في عارض الصور

صورة الغلاف المحلية
شارك
Cairo University Libraries Portal Implemented & Customized by: Eng. M. Mohamady Contacts: new-lib@cl.cu.edu.eg | cnul@cl.cu.edu.eg
CUCL logo CNUL logo
© All rights reserved — Cairo University Libraries
CUCL logo
Implemented & Customized by: Eng. M. Mohamady Contact: new-lib@cl.cu.edu.eg © All rights reserved — New Central Library
CNUL logo
Implemented & Customized by: Eng. M. Mohamady Contact: cnul@cl.cu.edu.eg © All rights reserved — Cairo National University Library